Literature DB >> 28128891

Nuclear-Targeted Multifunctional Magnetic Nanoparticles for Photothermal Therapy.

Haibao Peng1, Jing Tang2, Rui Zheng1, Guannan Guo1, Angang Dong3, Yajun Wang3, Wuli Yang1.   

Abstract

The pursuit of multifunctional, innovative, more efficient, and safer cancer treatment has gained increasing interest in the research of preclinical nanoparticle-mediated photothermal therapy (PTT). Cell nucleus is recognized as the ideal target for cancer treatment because it plays a central role in genetic information and the transcription machinery reside. In this work, an efficient nuclear-targeted PTT strategy is proposed using transferrin and TAT peptide (TAT: YGRKKRRQRRR) conjugated monodisperse magnetic nanoparticles, which can be readily functionalized and stabilized for potential diagnostic and therapeutic applications. The monodisperse magnetic nanoparticles exhibit high photothermal conversion efficiency (≈37%) and considerable photothermal stability. They also show a high magnetization value and transverse relaxivity (207.1 mm-1 s-1 ), which could be applied for magnetic resonance imaging. The monodisperse magnetic nanoparticles conjugated with TAT peptides can efficiently target the nucleus and achieve the imaging-guided function, efficient cancer cells killing ability. Therefore, this work may present a practicable strategy to develop subcellular organelle targeted PTT agents for simultaneous cancer targeting, imaging, and therapy.
© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  TAT; magnetic nanoparticle; nuclear-targeted; photothermal therapy; transferrin

Mesh:

Substances:

Year:  2017        PMID: 28128891     DOI: 10.1002/adhm.201601289

Source DB:  PubMed          Journal:  Adv Healthc Mater        ISSN: 2192-2640            Impact factor:   9.933


  13 in total

1.  Magnetic Nanoparticle-Mediated Heating for Biomedical Applications.

Authors:  Elyahb Allie Kwizera; Samantha Stewart; Md Musavvir Mahmud; Xiaoming He
Journal:  J Heat Transfer       Date:  2022-01-18       Impact factor: 2.021

Review 2.  Iron Oxide Nanoparticles in Photothermal Therapy.

Authors:  Joan Estelrich; Maria Antònia Busquets
Journal:  Molecules       Date:  2018-06-28       Impact factor: 4.411

Review 3.  Biologically Targeted Magnetic Hyperthermia: Potential and Limitations.

Authors:  David Chang; May Lim; Jeroen A C M Goos; Ruirui Qiao; Yun Yee Ng; Friederike M Mansfeld; Michael Jackson; Thomas P Davis; Maria Kavallaris
Journal:  Front Pharmacol       Date:  2018-08-02       Impact factor: 5.810

4.  Zwitterionic Polymer-Gated Au@TiO2 Core-Shell Nanoparticles for Imaging-Guided Combined Cancer Therapy.

Authors:  Tao Zheng; Wentao Wang; Fan Wu; Ming Zhang; Jian Shen; Yi Sun
Journal:  Theranostics       Date:  2019-07-09       Impact factor: 11.556

Review 5.  Subcellular Performance of Nanoparticles in Cancer Therapy.

Authors:  Chen-Guang Liu; Ya-Hui Han; Ranjith Kumar Kankala; Shi-Bin Wang; Ai-Zheng Chen
Journal:  Int J Nanomedicine       Date:  2020-02-05

Review 6.  Active Cellular and Subcellular Targeting of Nanoparticles for Drug Delivery.

Authors:  Okhil K Nag; James B Delehanty
Journal:  Pharmaceutics       Date:  2019-10-18       Impact factor: 6.321

Review 7.  MRI-traceable theranostic nanoparticles for targeted cancer treatment.

Authors:  Tareq Anani; Shiva Rahmati; Nayer Sultana; Allan E David
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

Review 8.  Bio-Inspired Protein-Based Nanoformulations for Cancer Theranostics.

Authors:  Yi Gou; Dandan Miao; Min Zhou; Lijuan Wang; Hongyu Zhou; Gaoxing Su
Journal:  Front Pharmacol       Date:  2018-04-27       Impact factor: 5.810

Review 9.  Membrane Trafficking and Subcellular Drug Targeting Pathways.

Authors:  Ajay Kumar; Anas Ahmad; Akshay Vyawahare; Rehan Khan
Journal:  Front Pharmacol       Date:  2020-05-27       Impact factor: 5.810

10.  Dihydroartemisinin-Loaded Magnetic Nanoparticles for Enhanced Chemodynamic Therapy.

Authors:  Shengdi Guo; Xianxian Yao; Qin Jiang; Kuang Wang; Yuanying Zhang; Haibao Peng; Jing Tang; Wuli Yang
Journal:  Front Pharmacol       Date:  2020-03-10       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.